C2 Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral??* Formulation
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in BioDrugs
- Vol. 15 (5) , 279-290
- https://doi.org/10.2165/00063030-200115050-00001
Abstract
Profiling of absorption of cyclosporin microemulsion (Neoral®) is a concept in therapeutic drug monitoring (TDM) designed to further optimise the clinical benefits of this formulation in transplant...Keywords
This publication has 13 references indexed in Scilit:
- Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant RecipientsClinical Pharmacokinetics, 2000
- STIMULATED RESPONSE OF PERIPHERAL LYMPHOCYTES MAY DISTINGUISH CYCLOSPORINE EFFECT IN RENAL TRANSPLANT RECIPIENTS RECEIVING A CYCLOSPORINE+RAPAMYCIN REGIMEN1Transplantation, 2000
- THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1Transplantation, 1999
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- PEAK CYCLOSPORINE LEVELS (Cmax) CORRELATE WITH FREEDOM FROM LIVER GRAFT REJECTIONTransplantation, 1999
- Neoral is superior to FK 506 in liver transplantationTransplantation Proceedings, 1998
- Low intrapatient variability of blood cyclosporine levels is correlated with excellent graft survivalTransplantation Proceedings, 1997
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993
- CyclosporineNew England Journal of Medicine, 1989